These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 7622144

  • 1. Prognostic factors in myelodysplastic syndromes: analysis of five scoring systems.
    Rubio-Felix D, Giraldo P, Franco E, Gimeno J, Giralt M.
    Hematol Oncol; 1995; 13(3):139-52. PubMed ID: 7622144
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Retrospective analysis of hemotherapy support in 226 cases of myelodysplastic syndromes].
    Rubio-Félix D, Franco E, Giraldo P, Gimeno J, Cuesta I, Giralt M.
    Sangre (Barc); 1994 Apr; 39(2):117-20. PubMed ID: 8059289
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival.
    Bernasconi P, Alessandrino EP, Boni M, Bonfichi M, Morra E, Lazzarino M, Campagnoli C, Astori C.
    Am J Hematol; 1994 Aug; 46(4):270-7. PubMed ID: 8037176
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis.
    Tricot G, Vlietinck R, Boogaerts MA, Hendrickx B, De Wolf-Peeters C, Van den Berghe H, Verwilghen RL.
    Br J Haematol; 1985 May; 60(1):19-32. PubMed ID: 3859319
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Increased expression of c-myc p67 oncoprotein in patients with myelodysplastic syndromes in transformation to acute leukaemia.
    Kyriakou D, Eliopoulos AG, Alexandrakis M, Kalokyri I, Eliopoulos GD.
    Haematologia (Budap); 1996 May; 28(1):1-7. PubMed ID: 9283897
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinico-pathological analysis of myelodysplastic syndromes according to French-American-British classification and international prognostic scoring system.
    Lau LG, Chng WJ, Liu TC, Tan LK, Ong KH, Mow BM, Kueh YK.
    Ann Acad Med Singap; 2004 Sep; 33(5):589-95. PubMed ID: 15531954
    [Abstract] [Full Text] [Related]

  • 20. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S, Mick R, Xu F, Stonys E, Le Beau MM, Larson R, Vardiman JW.
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.